Shopping Cart
- Remove All
- Your shopping cart is currently empty
IMB-808 is an LXRα/β dual agonist that promotes ABCA1 expression and cholesterol efflux without inducing lipidogenesis in HepG2 cells. IMB-808 can be used in atherosclerosis research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $50 | In Stock |
Description | IMB-808 is an LXRα/β dual agonist that promotes ABCA1 expression and cholesterol efflux without inducing lipidogenesis in HepG2 cells. IMB-808 can be used in atherosclerosis research. |
Targets&IC50 | LXRβ:0.53 μM (EC50), LXRα:0.15 μM (EC50) |
In vitro | IMB-808 exhibited a significant dose-dependent effect in the concentration range of 0.001 μM to 30 μM by activating LXRβ with an EC50 of 0.53 μM. In addition, IMB-808 was able to activate LXRα in a dose-dependent manner in a luciferase reporter gene assay with the GAL4-pGL4-luc reporter plasmid with an EC50 of 0.15 μM. M.[1] IMB-808 (0 μM-10 μM; 18 hours) significantly increased the protein and mRNA levels of ABCG1 and ABCA1 in RAW264.7 macrophage. [1] IMB-808 (0.1 μM-10 μM; 24 h) enhanced cholesterol efflux capacity in a dose-dependent manner while decreasing cellular cholesterol concentration in cell lines. [1] |
Alias | IMB808 |
Molecular Weight | 380.32 |
Formula | C18H15F3N2O4 |
Cas No. | 870768-70-0 |
Smiles | O=C(C1=CC=C2OCCOC2=C1)N(C)CC(=O)NC3=CC=C(F)C(F)=C3F |
Relative Density. | no data available |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 200 mg/mL (525.87 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.